Slogan: Harnessing data analytics to deliver the right specialty drugs at the right time, reducing costs and enhancing patient outcomes.
Description: Specialty drugs represent a small fraction—2%—of all pharmaceuticals sold, yet by 2018 they will constitute half of all drug expenditures. Pinscriptive leverages advanced big-data analytics and collaborative methodologies to match the right drugs with the right patients at optimal times, reducing costs and enhancing outcomes. Essentially, Pinscriptive provides evidence-based, value-driven decision support for at-risk providers and payers aiming to make informed specialty drug choices. In the U.S. alone, there's an estimated $20 billion in annual inefficiencies related to specialty drugs that can be addressed. By determining which medications work best for individual patients (precision analytics for precision medicine), Pinscriptive can substantially cut costs for both providers and payers. Additionally, the business model fosters collaboration with biopharma companies, who also face pay-for-performance challenges through risk-based contracting.
Founded: 2015
Industries: Analytics, Health Care, Payments
Last Investment: $1.78M Venture Round investment at 12 October 2016
Last Investment Investors: Not disclosed
